Clinical Trial Participation in Indian Gynecologic Oncology–Why Accrual Remains Poor and What Needs to Change

Indian Journal of Gynecologic Oncology · Published 2026-06-15 · DOI 10.1007/s40944-026-01130-4

Free full text

Authors (1)

Vijay K. Ahuja

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ahuja, V. (2026). Clinical Trial Participation in Indian Gynecologic Oncology–Why Accrual Remains Poor and What Needs to Change. Indian Journal of Gynecologic Oncology. https://doi.org/10.1007/s40944-026-01130-4

Related articles

• Sacituzumab Tirumotecan in the Evolving Landscape of Ovarian Cancer Treatment · Indian Journal of Gynecologic Oncology · 2026 · Same journal
• Triple Pathology in a Post-hysterectomized Woman: STIC, Borderline Serous Ovarian Tumor, and Benign Mucinous Cystadenoma: A Case Report and Review of Literature · Indian Journal of Gynecologic Oncology · 2026 · Same journal
• Understanding Borderline Ovarian Tumor : A Retrospective Analysis at Tertiary Cancer Centre · Indian Journal of Gynecologic Oncology · 2026 · Same journal
• Pre-Treatment Neutrophil to Lymphocyte Ratio and Cervical Cancer Outcomes in Indian Women: A Prognostic Evaluation · Indian Journal of Gynecologic Oncology · 2026 · Same journal
• A Rare Case of Follicular Dendritic Cell Sarcoma Masquerading as Ovarian Sex Cord Stromal Tumor · Indian Journal of Gynecologic Oncology · 2026 · Same journal
• Irreversible Electroporation in Ovarian Cancer: A Comprehensive Review of Therapeutic and Research Applications · Indian Journal of Gynecologic Oncology · 2026 · Same journal
• Juvenile Granulosa Cell Ovarian Tumour- Case Study with Radio-pathological Correlation · Indian Journal of Gynecologic Oncology · 2025 · Same journal
• Molecular Epidemiological Analysis on CYP1A1 m1 (rs4646903) and m2 (rs1048943) Polymorphisms to Correlate Cancerous and Precancerous Lesions of Uterine Cervix · Indian Journal of Gynecologic Oncology · 2026 · Same journal
• The Clinical Utility of Dual Energy Computed Tomography Quantitative Parameters in Evaluating Immunohistochemical (IHC) Biomarkers - Estrogen Receptor (ER), Progesterone Receptor (PR) And HER 2 (Herceptin 2 Receptor) in Invasive Breast Cancer: A Prospective Study · Indian Journal of Gynecologic Oncology · 2026 · Same journal
• A Rare Case of Ovarian Dysgerminoma in an 11 Year Old with Swyer Syndrome-A Case Report · Indian Journal of Gynecologic Oncology · 2026 · Same journal